This message was sent to ##Email##
Registration for the ASHI Regional Education Workshop 1 in Las Vegas, Nevada from April 12-14, 2018 is available. Register by Tuesday, March 13th to take advantage of our early registration rates.
Workshop 2 Keynote
|Dr. Carrie Schinstock, PhD
|Dr. Robert L Fairchild, PhD
Cleveland Clinic Lerner College
of Medicine and Case Western
Reserve University School
To learn more about our keynotes, click here.
The American Board of Histocompatibility and Immunogenetics (ABHI) has approved the Regional Education Workshops content for a maximum of 15.25 contact hours or 2.2075 CECs of continuing education hours for each series participated. Click here to view the preliminary program.
Travel Fund Awards
Regional Education Workshop 2 deadline is Friday, March 16, 2018. Travel awards are available to qualified applicants. Click here to apply.
SAVE THE DATE!
ASHI REGIONAL EDUCATION WORKSHOP 2:
Hilton Garden Inn Cleveland Downtown
1100 Carnegie Ave.
June 28-30, 2018
Check back often for more information about the 2018 ASHI Regional Education Workshops.
The abstract submission site is open for the 44th Annual Meeting. Abstracts may be accepted for either an oral presentation or a poster presentation. Before you prepare and submit your abstract, please carefully review the abstract requirements.
Submit Your Abstract Now
Deadline to Submit: April 9, 2018 at 11:59 CT
Important - Abstract Submission Fee
Beginning in 2018, there is a non-refundable abstract fee of $30 USD per abstract, due at the time of abstract submission. Click here for details.
VxMatch now features full LIMS integration, MFI cut-offs and custom visualizations. VxMatch is a dedicated application that displays DSA trends, dilution and reactivity history and has been validated at leading HLA labs. Click here to schedule a full demo or view our recent ASHI poster on VxMatch to learn more.
The NMDP/Be The Match has extended an invitation to ASHI and the HLA community to participate in their Walk+Run events. Be The Match Walk+Run is a fundraising event that helps patients with blood cancers like leukemia find a marrow donor and receive a life-saving transplant. These events will be held in:
Philadelphia - Saturday, April 14
Chicago - Sunday, May 6
Minneapolis - Saturday, May 12
Click here to register for any of these events. Save $5 by using this special discount code "community"!
Contact Erin Forsell at firstname.lastname@example.org for more information.
The 2017 HT-2 and EMO-2 Summary and Performance Reports are now available in the OLD PT Lab Center. Click here to login to the old PT Lab Center to view your reports. Please use your former login information (email address and corresponding password) to log into the old PT Lab Center.
If your laboratory subscribed to the 2017 AC-2 survey, the Summary and Performance reports are not yet finalized. You will be notified by email once they are available for your review. We appreciate your patience with report release delays as we work to integrate our new ASHI PT software and reporting systems.
2018 PT Ordering Tips and Information
The deadline for placing your 2018 PT order is Feb. 16, so if your lab has not placed a 2018 PT order, please be sure to log into the new PT Lab Center with your Lab's log-in information to place your order.
Click here for information regarding PO's, paper forms, and problems logging-in.
The ASHI Career Center will help ensure your recruitment advertising efforts attract the hard-to-reach candidates you seek. Here's how...
Ready to find the perfect candidate? Click here to get started!
- Posting jobs to a niche site like the ASHI Career Center provides your ad exposure to highly qualified professionals instead of the unqualified masses.
- Upgrading your job listings to ensure they appear high on search results drives significantly more views, clicks and applies.
- Supplementing job postings with banner ads can help build your brand as a desirable employer and attract the best candidates.
Name & Credentials: John Chappelle, CHT(ABHI), MLS(ASCP)CM
Job Title: Senior HLA Medical Technologist
Place of employment: Memorial Hermann Health System
Graduated from: The University of North Carolina at Wilmington
How long have you been an ASHI member? 4 years
When did you attend your first ASHI meeting? My first meeting was the ASHI Regional in Seattle.
Click here to read more.
To be our next ASHI Member Spotlight, click here now! You can also nominate a co-worker or fellow colleague by contacting Mandi Cruz at Mcruz@ashi-hla.org.
On Friday, February 23, 2018 at 12:00PM EDT ASHI Member/Board Member Dr. Robert Liwski will be facilitating a Pathology Grand Rounds Seminar & Webinar on HLA Testing and Kidney Transplant Allocation in Canada. Click here to learn more.
ASHI will sponsor two joint symposia at FOCIS 2018 - one with the American Society of Transplantation and The Transplantation Society and the other with The Association of Medical Laboratory Immunologists. FOCIS is the meeting in translational immunology that will give you a competitive edge in your career.
Click here to register today!
Do you want to learn new skills? Meet new people? Advance in your career? Sign up to be an ASHI Volunteer! Learn more about the many benefits of volunteering by visiting the ASHI WANTS YOU volunteer page on the ASHI website.
We also offer several easy, low-commitment tasks. So, if you are not sure about volunteering, or simply can't make a full commitment, try out one of our micro-volunteering opportunities. Sign up today by clicking here!
Did you know that ASHI is different from ABHI?
Although similar in some ways, ASHI, or the American Society for Histocompatibility and Immunogenetics offers individual membership, lab accreditation, proficiency testing, educational opportunities to earn CE including meetings and ASHI University, and scientific publications.
ABHI is the American Board for Histocompatibility and Immunogenetics and is for individual certification. For matters involving becoming certified or maintaining your CHA, CHT, CHS, or D(ABHI), you will need to contact ABHI.
Throughout 2018, the ASHI Membership Committee is releasing a 4-part member survey. Feedback from our members is critical to improving services and member experiences. Please take a moment to rate your experience with ASHI Membership in the first survey: Engagement & Satisfaction.
Responses are due no later than Thursday, February 22. For each survey, ASHI will reward one lucky participant with a $25 VISA gift card!
In June 2015, the OPTN/UNOS Board of Directors approved a rewrite of the histocompatibility bylaws that included the general supervisor to the list of laboratory key personnel. The implementation of the addition of this new requirement was delayed to allow for the development of a new key personnel application form, which then needed approval by the Office of Management and Budget (OMB). The OMB has recently approved the new general supervisor key personnel application form.
As part of the implementation of this bylaw, UNOS will send the OPTN general supervisor key personnel application to all OPTN approved histocompatibility laboratories. All approved histocompatibility laboratories will be asked to complete and submit the general supervisor key personnel application form within 30 days.
The effective date of the general supervisor key personnel requirement bylaw will coincide with the date that the Membership and Professional Standards Committee acts on all the general supervisor applications received during the 30-day submission period. All OPTN approved histocompatibility laboratories will need to submit this form within the 30-day period to remain in compliance with the histocompatibility laboratory membership requirements. If UNOS receives the application after the deadline, UNOS cannot guarantee that it will be processed prior to the implementation date. The new bylaw language can be found in the Histocompatibility Bylaws Rewrite Phase II policy notice on the OPTN website. UNOS will implement the general supervisor key personnel requirement for histocompatibility laboratories on the following schedule:
February 27, 2018: Effective date of general supervisory key personnel bylaw. Notice will be provided 30 days prior to the effective date.
If you have any questions, please contact Christi Manner, Jasmine Smith or Tierra Simpkins by phone at (804) 782-4800 or by email using the format email@example.com.
The Travel Fund Award was created to help new ASHI members attend regional and annual meetings. ASHI is able to continue its mission because of your support and generosity. By contributing to the travel fund award, you'll help us give more educational and career building opportunities to our members.
Online donations are quick and easy using our secure credit card transactions. We welcome donations of all sizes. Donate today by clicking here!
Have you renewed your ASHI membership for 2018? If not, do it now to avoid a disruption of your ASHI benefits!
ASHI Memberships expired on December 31, 2017. Your membership dues allow us to provide programs, professional awards, and educational opportunities that advance the science, education and application of immunogenetics and transplant immunology. Click here to renew today!
If you are experiencing trouble with your ASHI website username or password, contact Membership Coordinator, Mandi Cruz at firstname.lastname@example.org.
ABO-incompatible (ABOi) kidney transplantation has become an established strategy to increase the number of available living donors. At our center, the conditioning protocol for ABOi patients is based on anti-A/B antibody removal and depletion of B cells with the anti-CD20 mAb rituximab (Mabthera®). It is known that even low amounts of remaining rituximab in serum of patients results in false positive B cell cross match results, masking detection of potentially harmful donor human leukocyte antigen (HLA) specific antibodies.
The aim of this case-control study was to elucidate the role of some single nucleotide polymorphisms (SNPs) in the ERAP1 (rs27524, rs27044, rs30187, rs2287987 and rs26653) and ERAP2 (rs2248374) genes in predicting the risk for psoriasis vulgaris in the Polish population. ERAP1, ERAP2 and HLA-C*06:02 typing was done using the TaqMan SNP genotyping assays. We confirmed a strong association of the HLA-C*06:02 allele with early-onset psoriasis. In ERAP1, rs30187T increased the risk of psoriasis in HLA-C*06:02-positive patients, most strongly in late onset psoriasis, whereas it was protective when the HLA-C*06:02 allele was absent.
For over 50 years, the International HLA and Immunogenetics Workshops (IHIW) have advanced the fields of histocompatibility and immunogenetics (H&I) via community sharing of technology, experience and reagents, and the establishment of ongoing collaborative projects. Held in the fall of 2017, the 17th IHIW focused on the application of next generation sequencing (NGS) technologies for clinical and research goals in the H&I fields. NGS technologies have the potential to allow dramatic insights and advances in these fields, but the scope and sheer quantity of data associated with NGS raise challenges for their analysis, collection, exchange and storage.
50 Minthorn Blvd.Suite 800, Thornhill, Ontario L3T 7X8